Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci

Yuli Song; Sydney M. Finegold

doi:10.1128/9781555816728.ch48

Chapter 48 : Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci

Authors: Yuli Song, Sydney M. Finegold

Content Type: Reference

Publication Year: 2011

Category: Clinical Microbiology

Book DOI: 10.1128/9781555816728

Chapter DOI: 10.1128/9781555816728.ch48

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap48-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap48-2.gif

Abstract:

The organisms included in this chapter are obligately anaerobic, non-spore-forming, sometimes elongated cocci. The genera Anaerococcus, Anaerosphaera, Finegoldia, Gallicola, Parvimonas, Peptococcus, Peptoniphilus, and Peptostreptococcus, as well as the newly described taxon Murdochiella , are gram-positive, coccobacillary, or, occasionally, coccoid cells. F. magna is the most pathogenic and one of the most frequently isolated gram-positive anaerobic coccal species found in human clinical specimens. Molecular methods, such as nucleic acid probe hybridization and PCR amplification, are not yet standardized or available commercially for the direct demonstration of medically important gram-positive anaerobic cocci from clinical specimens. New information regarding the antimicrobial susceptibilities of gram-positive anaerobic cocci is sparse compared with the information available for other anaerobic species. Bacteria present in pure culture or in large numbers are probably of major importance, as are organisms recovered in multiple cultures and isolated from normally sterile sites. Furthermore, Gram stain results can guide the laboratory in choosing media for optimal recovery of the predicted organisms. The significance of finding anaerobic gram-positive and gram-negative cocci in clinical specimens depends on the specimen and the likelihood that it was contaminated by the microbiota of the skin or mucous membranes. Hence, interpretation of culture results is dependent on the nature and quality of the specimen submitted to the laboratory.

Citation: Song Y, Finegold S. 2011. Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci, p 803-816. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch48

Key Concept Ranking

Upper Respiratory Tract Infections: 0.42861545
Gram-Positive Cocci: 0.42077577
Restriction Fragment Length Polymorphism: 0.41200244
Gram-Negative Bacteria: 0.40224198

0.42861545

Highlighted Text: Show | Hide

Full text loading...

Figures

Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816728.chap48-1,webId=/content/author/10.1128/9781555816728.chap48-1,properties={foaf_givenname=Yuli, foaf_name=Yuli Song, foaf_surname=Song}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555816728.chap48-2,webId=/content/author/10.1128/9781555816728.chap48-2,properties={foaf_givenname=Sydney M., foaf_name=Sydney M. Finegold, foaf_surname=Finegold}]]

/content/10.1128/9781555816728.chap48.fig48-1

FIGURE 1

Flowchart with key characteristics for identification and differentiation of gram-positive anaerobic cocci. a, SPS testing was done using an SPS disk (Anaerobe Systems, Morgan Hill, CA). All gram-positive anaerobic cocci are sensitive to SPS except for P. anaerobius, which gives a zone of inhibition of ≥12 mm around an SPS disk. P. micros also exhibits a zone of inhibition with SPS; however, the zone is usually <12 mm in size. +, no zone or the zone of inhibition is <12 mm; –, the zone of inhibition is ≥12 mm. b, all the enzymatic tests were done by using the Rapid ID 32A system (API bioMérieux, Marcy l'Etoile, France) according to the manufacturer's instructions. β-Gal, β-galactosidase; α-Glu, α-glucosidase; β-Gur, β-glucuronidase; ArgA, arginine arylamidase (AMD); ProA, proline AMD; PheA, phenylalanine AMD; PyrA, pyroglutamyl AMD; GGA, glutamyl glutamic acid AMD; ALP, alkaline phosphatase. c, glucose fermentation tests were performed using PRAS peptone-yeast-glucose (PYG) broth (Anaerobe Systems, Morgan Hill, CA). A pH of ≤5.5 in the PYG tubes was interpreted as positive and a pH of ≥5.9 as negative fermentation. d, described by D. A. Murdoch and I. J. Mitchelmore ( 80 ).

10.1128/9781555816728/fig48-1_thmb.gif

10.1128/9781555816728/fig48-1.gif

FIGURE 1

References

/content/book/10.1128/9781555816728.chap48

1. Al Masalma, M.,, F. Armougom,, W. M. Scheld,, H. Dufour,, P.-H. Roche,, M. Drancurt,, and D. Raoult. 2009. The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin. Infect. Dis. 48: 1169– 1178.

2. Arif, N.,, T. Do,, R. Byun,, E. Sheehy,, D. Clark,, S. C. Gilbert,, and D. Beighton. 2008. Veillonella rogosae sp. nov., an anaerobic, Gram-negative coccus isolated from dental plaque. Int. J. Syst. Evol. Microbiol. 58: 581– 584.

3. Bartz, H.,, C. Nonnenmacher,, C. Bollmann,, M. Kuhl,, S. Zimmermann,, K. Heeg,, and R. Mutters. 2005. Micromonas (Peptostreptococcus) micros: unusual case of prosthetic joint infection associated with dental procedures. Int. J. Med. Microbiol. 294: 465– 470.

4. Beighton, D.,, D. Clark,, B. Hanakuka,, S. Gilbert,, and T. Do. 2008. The predominant cultivable Veillonella spp. of the tongue of healthy adults identified using rpoB sequencing. Oral Microbiol. Immunol. 23: 344– 347.

5. Beumont, M. G.,, J. Duncan,, S. D. Mitchell,, J. L. Esterhai, Jr.,, and P. H. Edelstein. 1995. Veillonella myositis in an immunocompromised patient. Clin. Infect. Dis. 21: 678– 679.

6. Bhatti, M. A.,, and M. O. Frank. 2000. Veillonella parvula meningitis: case report and review of Veillonella infections. Clin. Infect. Dis. 31: 839– 840.

7. Biagi, E.,, B. Vitali,, C. Pugliese,, M. Candela,, G. G. Donders,, and P. Brigidi. 2009. Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur. J. Clin. Microbiol. Infect. Dis. 28: 281– 285.

8. Björck, L. 1988. Protein L: a novel bacterial cell wall protein with affinity for Ig L chains. J. Immunol. 140: 1194– 1197.

9. Blome, B.,, A. Braun,, V. Sobarzo,, and S. Jepsen. 2008. Molecular identification and quantification of bacteria from endodontic infections using real-time polymerase chain reaction. Oral Microbiol. Immunol. 23: 384– 390.

10. Bourgault, A.-M.,, J. E. Rosenblatt,, and R. H. Fitzgerald. 1980. Peptococcus magnus: a significant human pathogen. Ann. Intern. Med. 93: 244– 248.

11. Boutaga, K.,, A. J. van Winkelhoff,, C. M. Vandenbroucke-Grauls,, and P. H. Savelkoul. 2005. Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunol. Med. Microbiol. 45: 191– 199.

12. Boutaga, K.,, P. H. Savelkoul,, E. G. Winkel,, and A. J. van Winkelhoff. 2007. Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. J. Periodontol. 78: 79– 86.

13. Boyanova, L.,, R. Kolarov,, G. Gergova,, E. Deliverska,, J. Madjarov,, M. Marinov,, and I. Mitov. 2006. Anaerobic bacteria in 118 patients with deep-space head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria. J. Med. Microbiol. 55: 1285– 1289.

14. Brazier, J.,, D. Chmelar,, L. Dubreuil,, G. Feierl,, M. Hedberg,, S. Kalenic,, E. Könönen,, B. Lundgren,, H. Malamou-Ladas,, E. Nagy,, A. Sullivan,andC.E.Nord; ESCMID Study Group on Antimicrobial Resistance in AnaerobicBacteria. 2008. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci. Int. J. Antimicrob. Agents 31: 316– 320.

15. Brazier, J. S.,, V. Hall,, T. E. Morris,, M. Gal,, and B. I. Duerden. 2003. Antibiotic susceptibilities of Gram-positive anaerobic cocci: results of a sentinel study in England and Wales. J. Antimicrob. Chemother. 52: 224– 228.

16. Brook, I. 1986. Encapsulated anaerobic bacteria in synergistic infections. Microbiol. Rev. 50: 452– 457.

17. Brook, I. 1989. Anaerobic bacteria in suppurative genitourinary infections. J. Urol. 141: 889– 893.

18. Brook, I.,, and E. H. Frazier. 1990. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch. Surg. 125: 1445– 1451.

19. Brook, I.,, and E. H. Frazier. 1992. Infections caused by Veillonella species . Infect. Dis. Clin. Pract. 1: 377– 381.

20. Brook, I. 1996. Veillonella infections in children. J. Clin. Microbiol. 34: 1283– 1285.

21. Brook, I. 2004. Intra-abdominal, retroperitoneal, and visceral abscesses in children. Eur. J. Pediatr. Surg. 14: 265– 273.

22. Buduneli, N.,, H. Baylas,, E. Buduneli,, O. Türko?lu,, T. Köse,, and G. Dahlen. 2005. Periodontal infections and pre-term low birth weight: a case-control study. J. Clin. Periodontol. 32: 174– 181.

23. Byun, R.,, J. P. Carlier,, N. A. Jacques,, H. Marchandin,, and N. Hunter. 2007. Veillonella denticariosi sp. nov., isolated from human carious dentine. Int. J. Syst. Evol. Microbiol. 57: 2844– 2848.

24. Carlier, J.-P.,, H. Marchandin,, E. Jumas-Bilak,, V. Lorin,, C. Henry,, C. Carriere,, and H. Jean-Pierre. 2002. Anaeroglobus geminatus gen. nov., sp. nov., a novel member of the family Veillonellaceae. Int. J. Syst. Evol. Microbiol. 52: 983– 986.

25. Citron, D. M.,, Y. Y. Kwok,, and M. D. Appleman. 2005. In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic gram-positive cocci. Anaerobe 11: 93– 95.

26. Civen, R.,, M.-L. Väisänen,, and S. M. Finegold. 1993. Peritonsillar abscess, retropharyngeal abscess, mediastinitis, and nonclostridial anaerobic myonecrosis: a case report. Clin. Infect. Dis. 16( Suppl. 4): S299– S303.

27. Collins, M. D.,, and S. Wallbanks. 1992. Comparative sequence analyses of the 16S rRNA genes of Lactobacillus minutus, Lactobacillus rimae and Streptococcus parvulus: proposal for the creation of a new genus, Atopobium. FEMS Microbiol. Lett. 95: 235– 240.

28. Collins, M. L. Z.,, W. A. Falkler,, E. R. Hall,, and M. B. Graham. 1989. Serological studies of peptostreptococci using an indirect fluorescent antibody test. J. Dent. Res. 68: 1508– 1512.

29. Davies, U. M.,, A. M. Leak,, and J. Dave. 1988. Infection of a prosthetic knee joint with Peptostreptococcus magnus. Ann. Rheumat. Dis. 47: 866– 868.

30. de Château, M.,, and L. Björck. 1994. Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J. Biol. Chem. 269: 12147– 12151.

31. Delaney, M. L.,, and A. B. Onderdonk. 2001. Nugent score related to vaginal culture in pregnant women. Obstet. Gynecol. 98: 79– 84.

32. Domingo, M.-C.,, A. Huletsky,, M. Boissinot,, K. A. Bernard,, F. J. Picard,, and M. G. Bergeron. 2008. Ruminococcus gauvreauii sp. nov., a glycopeptide-resistant species isolated from a human faecal specimen. Int. J. Syst. Evol. Microbiol. 68: 1393– 1397.

33. Downes, J.,, and W. G. Wade. 2006. Peptostreptococcus stomatis sp. nov., isolated from the human oral cavity. Int. J. Syst. Evol. Microbiol. 56: 751– 754.

34. Edmiston, C. E., Jr.,, A. P. Walker,, C. J. Krepel,, and C. Gohr. 1990. The nonpuerperal breast infection: aerobic and anaerobic microbial recovery from acute and chronic disease. J. Infect. Dis. 162: 695– 699.

35. Ednie, L.,, S. Shapiro,, and P. C. Appelbaum. 2007. Antianaerobic activity of ceftobiprole, a new broad-spectrum cephalosporin. Diagn. Microbiol. Infect. Dis. 58: 133– 136.

36. Egwari, L.,, V. O. Rotimi,, O. O. Abudu,, and A. O. Coker. 1995. A study of the anaerobic bacterial flora of the female genital tract in health and disease. Cent. Afr. J. Med. 41: 391– 397.

37. Ezaki, T.,, N. Yamamoto,, K. Ninomiya. S. Suzuki, and E. Yabuuchi. 1983. Transfer of Peptococcus indolicus, Peptococcus asaccharolyticus, Peptococcus prevotii, , and Peptococcus magnus to the genus Peptostreptococcus and proposal of Peptostreptococcus tetradius sp. nov. Int. J. Syst. Bacteriol. 33: 683– 698.

38. Ezaki, T.,, N. Li,, Y. Hashimoto,, H. Miura,, and H. Yamamoto. 1994. 16S ribosomal DNA sequences of anaerobic cocci and proposal of Ruminococcus hansenii comb. nov. and Ruminococcus productus comb. nov. Int. J. Syst. Bacteriol. 44: 130– 136.

39. Ezaki, T.,, Y. Kawamura,, N. Li,, Z. Y. Li,, L. Zhao,, and S. Shu. 2001. Proposal of the genera Anaerococcus gen. nov., Peptoniphilus gen. nov. and Gallicola gen. nov. for members of the genus Peptostreptococcus. Int. J. Syst. Evol. Microbiol. 51: 1521– 1528.

40. Fenner, L.,, A. F. Widmer,, C. Straub,, and R. Frei. 2008. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J. Clin. Microbiol. 46: 2432– 2434.

41. Finegold, S. M. 1995. Anaerobic infections in humans: an overview. Anaerobe 1: 3– 9.

42. Fitzgerald, R. H., Jr.,, J. E. Rosenblatt,, J. H. Tenney,, and A.-M. Bourgault. 1982. Anaerobic septic arthritis. Clin. Orthop. Rel. Res. 1982: 141– 148.

43. Fournier, P. E.,, M. V. La,, J. P. Casalta,, H. Richet,, F. Collart,, and D. Raoult. 2008. Finegoldia magna, an early postoperative cause of infectious endocarditis: report of two cases and review of the literature. Anaerobe 14: 310– 312.

44. Frick, I. M.,, C. Karlsson,, M. Mörgelin,, A. I. Olin,, R. Janjusevic,, C. Hammarström,, E. Holst,, M. de Château,, and L. Björck. 2008. Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen. Mol. Microbiol. 70: 695– 708.

45. Garrity, G. M.,, and J. G. Holt,. 2001. Taxonomic outlines of the Archaea and Bacteria, p. 155– 166. In D. R. Boone, and R. W. Castenholz (ed.), Bergey’s Manual of Systematic Bacteriology, 2nd ed. Springer, New York, NY.

46. Goldstein, E. J.,, G. Conrads,, D. M. Citron,, C. V. Merriam,, Y. Warren,, and K. Tyrrell. 2002. In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. Diagn. Microbiol. Infect. Dis. 42: 113– 118.

47. Goldstein, E. J. C.,, D. M. Citron,, C. V. Merriam,, Y. A. Warren,, K. L. Tyrrell,, and H. T. Fernandez. 2006. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections. Antimicrob. Agents Chemother. 50: 3959– 3962.

48. Goldstein, E. J. C.,, D. M. Citron,, Y. A. Warren,, K. L. Tyrrell,, C. V. Merriam,, and H. T. Fernandez. 2006. In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections. Antimicrob. Agents Chemother. 50: 2875– 2879.

49. Gomes, S. C.,, C. Nonnenmacher,, C. Susin,, R. V. Oppermann,, R. Mutters,, and R. A. Marcantonio. 2008. The effect of a supragingival plaque-control regimen on the subgingival microbiota in smokers and never-smokers: evaluation by real-time polymerase chain reaction. J. Periodontol. 79: 2297– 2304.

50. Gutierrez de Ferro, M. I.,, R.E. Ruiz de Valladares,, and I. L. Benito de Cardenas. 2005. Recovery of Veillonella from saliva. Rev. Argent. Microbiol. 37: 22– 25.

51. Hill, K. E.,, C. E. Davies,, M. J. Wilson,, P. Stephens,, M. A. Lewis,, V. Hall,, J. Brazier,, and D. W. Thomas. 2002. Heterogeneity within the gram-positive anaerobic cocci demonstrated by analysis of 16S-23S intergenic ribosomal RNA polymorphisms. J. Med. Microbiol. 51: 949– 957.

52. Holdeman-Moore, L. V.,, J. L. Johnson,, and W. E. C. Moore,. 1986. Genus Peptostreptococcus, p. 1083– 1092. In P. H. A. Sneath,, N. S. Mair,, M. E. Sharpe,, and J. G. Holt (ed.), Bergey’s Manual of Systematic Bacteriology, vol. 2. The Williams & Wilkins Co., Baltimore, MD.

53. Igarashi, E.,, A. Kamaguchi,, M. Fujita,, H. Miyakawa,, and F. Nakazawa. 2009. Identification of oral species of the genus Veillonella by polymerase chain reaction. Oral Microbiol. Immunol. 24: 310– 313.

54. Johnson, S.,, F. Lebahn,, L. R. Peterson,, and D. N. Gerding. 1995. Use of an anaerobic collection and transport swab device to recover anaerobic bacteria from infected foot ulcers in diabetics. Clin. Infect. Dis. 20: S289– S290.

55. Jousimies-Somer, H. R.,, P. Summanen,, D. Citron,, E. Baron,, H. M. Wexler,, and S. M. Finegold. 2002. Wadsworth-KTL Anaerobic Bacteriology Manual, 5th ed. Star Publishing, Belmont, CA.

56. Jumas-Bilak, E.,, J. P. Carlier,, H. Jean-Pierre,, C. Teyssier,, B. Gay,, J. Campos,, and H. Marchandin. 2004. Veillonella montpellierensis sp. nov., a novel, anaerobic, Gram-negative coccus isolated from human clinical samples. Int. J. Syst. Evol. Microbiol. 54: 1311– 1316.

57. Jumas-Bilak, E.,, J. P. Carlier,, H. Jean-Pierre,, F. Mory,, C. Teyssier,, B. Gay,, J. Campos,, and H. Marchandin. 2007. Acidaminococcus intestini sp. nov., isolated from human clinical samples. Int. J. Syst. Evol. Microbiol. 57: 2314– 2319.

58. Kanno, T.,, T. Matsuki,, M. Oka,, H. Utsunomiya,, K. Inada,, H. Magari,, I. Inoue,, T. Maekita,, K. Ueda,, S. Enomoto,, M. Iguchi,, K. Yanaoka,, H. Tamai,, S. Akimoto,, K. Nomoto,, R. Tanaka,, and M. Ichinose. 2009. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem. Biophys. Res. Commun. 381: 666– 670.

59. Karlsson, C.,, M.-L. Andersson,, M. Collin,, A. Schmidtchen,, L. Björck,, and I.-M. Frick. 2007. SufA—a novel subtilisin-like serine proteinase of Finegoldia magna. Microbiology 153: 4208– 4218.

60. Karlsson, C.,, M. Eliasson,, A. I. Olin,, M. Morgelin,, A. Karlsson,, M. Malmsten,, A. Egesten,, and I. M. Frick. 2009. SufA of the opportunistic pathogen Finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation. J. Biol. Chem. 284: 29499– 29508.

61. Koeth, L. M.,, C. E. Good,, P. C. Appelbaum,, E. J. Goldstein,, A. C. Rodloff,, M. Claros,, and L. J. Dubreuil. 2004. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. J. Antimicrob. Chemother. 53: 1039– 1044.

62. Kolenbrander, P. E.,, and L. V. H. Moore,. 1992. The genus Veillonella, p. 2034– 2047. In A. G. Balows,, M. Trüper,, W. Dworkin,, W. Harder,, and K.-H. Schleifer (ed.), The Prokaryotes, 2nd ed. Springer, New York, NY.

63. Könönen, E.,, A. Bryk,, P. Niemi,, and A. Kanervo-Nordström. 2007. Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources. Antimicrob. Agents Chemother. 51: 2205– 2207.

64. Korman, T. M.,, E. Athan,, and D. W. Spelman. 1997. Anaerobic meningitis due to Peptostreptococcus species: case report and review. Clin. Infect. Dis. 25: 1462– 1464.

65. Krepel, C. J.,, C. M. Gohr,, A. P. Walker,, S. G. Farmer,, and C. E. Edmiston. 1992. Enzymatically active Peptostreptococcus magnus: association with site of infection. J. Clin. Microbiol. 30: 2330– 2334.

66. Lehmann, L. E.,, K.-P. Hunfeld,, T. Emrich,, G. Haberhausen,, H. Wissing,, A. Hoeft,, and F. Stüber. 2008. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med. Microbiol. Immunol. 197: 313– 324.

67. Li, N.,, Y. Hashimoto,, S. Adnan,, H. Miura,, H. Yamamoto,, and T. Ezaki. 1992. Three new species of the genus Peptostreptococcus isolated from humans: Peptostreptococcus vaginalis sp. nov., Peptostreptococcus lacrimalis sp. nov., and Peptostreptococcus lactolyticus sp. nov. Int. J. Syst. Bacteriol. 42: 602– 605.

68. Liu, C.,, S. M. Finegold,, Y. Song,, and P. A. Lawson 2008. Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 58: 1896– 1902.

69. Liu, J. W.,, J. J. Wu,, L. R. Wang,, L. J. Teng,, and T. C. Huang. 1998. Two fatal cases of Veillonella bacteraemia. Eur. J. Clin. Microbiol. Dis. 17: 62– 64.

70. Maniglia, R. J.,, T. Roth,, and E. A. Blumberg. 1997. Polymicrobial brain abscess in a patient infected with human immunodeficiency virus. Clin. Infect. Dis. 24: 449– 451.

71. Marchandin, H.,, C. Teyssier,, C. Carriere,, F. Canovas,, H. Daras,, and E. Jumas-Bilak. 2001. Prosthetic joint infection due to Veillonella dispar. Eur. J. Clin. Microbiol. Infect. Dis. 20: 340– 342.

72. Marchandin, H.,, C. Teyssier,, J. Campos,, H. Jean-Pierre,, F. Roger,, B. Gay,, J.-P. Carlier,, and E. Jumas-Bilak. 2010. Negativicoccus succinovorans gen. nov., sp. nov., isolated from human clinical samples, emended description of the family Veillonellaceae and description of Negativicutes classis nov., Selenomonadales ord. nov., and Acidaminococcaceae fam. nov., in the bacterial phylum Firmicutes. Int. J. Syst. Evol. Microbiol. 60: 1271– 1279.

73. Marina, M.,, C. A. Strong,, R. Civen,, E. Molitoris,, and S. M. Finegold. 1993. Bacteriology of anaerobic pleuropulmonary infections: preliminary report. Clin. Infect. Dis. 16: S256– S262.

74. Marrazzo, J. M.,, K. K. Thomas,, T. L. Fiedler,, K. Ringwood,, and D. N. Fredricks. 2008. Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann. Intern. Med. 149: 20– 28.

75. Marriott, D.,, D. Stark,, and J. Harkness. 2007. Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy? J. Clin. Microbiol. 45: 672– 674.

76. Mitchelmore, I. J.,, A. J. Prior,, P. Q. Montgomery,, and S. Tabaqchali. 1995. Microbiological features and pathogenesis of peritonsillar abscesses. Eur. J. Clin. Microbiol. Infect. Dis. 14: 870– 877.

77. Montejo, M.,, G. Ruiz-Irastorza,, K. Aguirrebengoa,, E. Amutio,, J. L. Hernández,, and C. Aguirre. 1995. Prosthetic-valve endocarditis caused by Peptostreptococcus anaerobius. Clin. Infect. Dis. 20: 1431.

78. Moore, L. V. H.,, W. E. C. Moore,, and E. P. Cato. 1987. Bacteriology of human gingivitis. J. Dent. Res. 66: 989– 995.

79. Mory, F.,, A. Lozniewski,, S. Bland,, A. Sedallian,, G. Grollier,, F. Girard-Pipau,, M. F. Paris,, and L. Dubreuil. 1998. Survey of anaerobic susceptibility patterns: a French multicentre study. Int. J. Antimicrob. Agents 10: 229– 236.

80. Murdoch, D. A.,, and I. J. Mitchelmore. 1991. The laboratory identification of gram-positive anaerobic cocci. J. Med. Microbiol. 34: 295– 308.

81. Murdoch, D. A.,, I. J. Mitchelmore,, and S. Tabaqchali. 1994. The clinical importance of gram-positive anaerobic cocci isolated at St. Bartholomew’s Hospital, London, in 1987. J. Med. Microbiol. 41: 36– 44.

82. Murdoch, D. A. 1998. Gram-positive anaerobic cocci. Clin. Microbiol. Rev. 11: 81– 120.

83. Murdoch, D. A.,, and H. N. Shah. 1999. Reclassification of Peptostreptococcus magnus (Prevot 1933) Holdeman and Moore 1972 as Finegoldia magna comb. nov. and Peptostreptococcus micros (Prevot 1933) Smith 1957 as Micromonas micros comb. nov. Anaerobe 5: 555– 559.

84. Murdoch, D. A.,, H. N. Shah,, S. E. Gharbia,, and D. Rajendram. 2000. Proposal to restrict the genus Peptostreptococcus (Kluyver & van Niel 1936) to Peptostreptococcus anaerobius. Anaerobe 6: 257– 260.

85. Natto, S.,, M. Baljoon,, G. Dahlén,, and J. Bergström. 2005. Tobacco smoking and periodontal microflora in a Saudi Arabian population. J. Clin. Periodontol. 32: 549– 555.

86. Ng, L. S. Y.,, L. L. Kwang,, S. C. S. Yeow,, and T. Y. Tan. 2008. Anaerobic culture of diabetic foot infections: organisms and antimicrobial susceptibilities. Ann. Acad. Med. Singapore 37: 936– 939.

87. Nonnenmacher, C.,, M. Stelzel,, C. Susin,, A. M. Sattler,, J. R. Schafer,, B. Maisch,, R. Mutters,, and L. Flores-de-Jacoby. 2007. Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J. Periodontol. 78: 1724– 1730.

88. Ota-Tsuzuki, C.,, and M. P. Mayer. 2010. Collagenase production and hemolytic activity related to 16S rRNA variability among Parvimonas micra oral isolates. Anaerobe, 16: 38– 42.

89. Panagou, P.,, L. Papandreou,, and D. Bouros. 1991. Severe anaerobic necrotizing pneumonia complicated by pyopneumothorax and anaerobic monoarthritis due to Peptostreptococcus magnus. Respiration 58: 223– 225.

90. Pankuch, G. A.,, M. R. Jacobs,, and P. C. Appelbaum. 1993. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Antimicrob. Agents Chemother. 37: 1649– 1654.

91. Papaioannou, W.,, S. Gizani,, A. D. Haffajee,, M. Quirynen,, E. Mamai-Homata,, and L. Papagiannoulis. 2009. The microbiota on different oral surfaces in healthy children. Oral Microbiol. Immunol. 24: 183– 189.

92. Paster, B. J.,, M. K. Russell,, T. Alpagot,, A. M. Lee,, S. K. Bochs,, J. L. Galvin,, and F. E. Dewhirst. 2002. Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects. Ann. Periodontol. 7: 8– 16.

93. Periasamy, S.,, and P. E. Kolenbrander. 2009. Aggregatibacter actinomycetemcomitans builds mutualistic biofilm communities in saliva with Fusobacterium nucleatum and Veillonella sp. Infect. Immun. 77: 3542– 3551.

94. Petts, D. N.,, W. Champion,, and G. Raymond. 1988. Oxolinic acid as a selective agent for the isolation of non-sporing anaerobes from clinical material. Lett. Appl. Microbiol. 6: 65– 67.

95. Price, R. R.,, H. B. Viscount,, M. C. Stanley,, and K. P. Leung. 2007. Targeted profiling of oral bacteria in human saliva and in vitro biofilms with quantitative real-time PCR. Biofouling 23: 203– 213.

96. Rams, T. E.,, D. Feik,, M. A. Listgarten,, and J. Slots. 1992. Peptostreptococcus micros in human periodontitis. Oral Microbiol. Immunol. 7: 1– 6.

97. Rennie, R. P.,, C. Brosnikoff,, L. A. Turnbull,, L. B. Reller,, S. Mirrett,, W. Janda,, K. Ristow,, and A. Krilcich. 2008. Multicenter evaluation of the Vitek 2 Anaerobe and Corynebacterium identification card. J. Clin. Microbiol. 46: 2646– 2651.

98. Riggio, M. P.,, A. Lennon,, and A. Smith. 2001. Detection of Peptostreptococcus micros DNA in clinical samples by PCR. J. Med. Microbiol. 50: 249– 254.

99. Riggio, M. P.,, and A. Lennon. 2003. Specific PCR detection of Peptostreptococcus magnus. J. Med. Microbiol. 52: 309– 313.

100. Riggio, M. P.,, and A. Lennon. 2003. Identification of oral peptostreptococcus isolates by PCR-restriction fragment length polymorphism analysis of 16S rRNA genes. J. Clin. Microbiol. 41: 4475– 4479.

101. Riggio, M.P.,, H. Aga,, C.A. Murray,, M.S. Jackson,, A. Lennon,, N. HammersleyandJ.Bagg. 2007. Identification of bacteria associated with spreading odontogenic infections by16S rRNA gene sequencing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103: 610– 617.

102. Rôças, I. N.,, and J. F. Siqueira, Jr. 2006. Culture-independent detection of Eikenella corrodens and Veillonella parvula in primary endodontic infections. J. Endod. 32: 509– 512.

103. Rôças, I. N.,, and J. F. Siqueira, Jr. 2008. Root canal microbiota of teeth with chronic apical periodontitis. J. Clin. Microbiol. 46: 3599– 3606.

104. Rogosa, M. 1965. The genus Veillonella, IV. Serological groupings, and genus and species emendations. J. Bacteriol. 90: 704– 709.

105. Rowlinson, M.-C.,, P. LeBourgeois,, K. Ward,, Y.L. Song,, S.M. Finegold,, and D. A. Bruckner. 2006. Isolation of a strictly an aerobic strain of Staphylococcus epidermidis 44: 857– 860.

106. Ruviére, D. B.,, M. R. Leonardo,, L. A. da Silva,, I. Y. Ito,, and P. Nelson-Filho. 2007. Assessment of the microbiota in root canals of human primary teeth by checkerboard DNADNA hybridization. J. Dent. Child. (Chic.) 74: 118– 123.

107. Salin, F.,, F. Vianello,, R. Manara,, E. Morelli,, A. Cattelan,, M. Scarin,, and D. Sgarabotto. 2006. Linezolid in the treatment of brain abscess due to Peptostreptococcus. Scand. J. Infect. Dis. 38: 203– 205.

108. Sanchez, M. L.,, R. N. Jones,, and J. L. Croco. 1992. Use of the Etest to access macrolide-lincosamide resistance patterns among Peptostreptococcus species. Antimicrob. Newsl. 8: 45– 49.

109. Sassone, L.,, R. Fidel,, L. Figueiredo,, S. Fidel,, M. Faveri,, and M. Feres. 2007. Evaluation of the microbiota of primary endodontic infections using checkerboard DNA-DNA hybridization. Oral Microbiol. Immunol. 22: 390– 397.

110. Sato, T.,, J. Matsuyama,, M. Sato,, and E. Hoshino. 1997. Differentiation of Veillonella atypica, Veillonella dispar and Veillonella parvula using restricted fragment-length polymorphism analysis of 16S rDNA amplified by polymerase chain reaction. Oral Microbiol. Immunol. 12: 350– 353.

111. Sato, T.,, M. Sato,, J. Matsuyama,, and E. Hoshino. 1997. PCR-restriction fragment length polymorphism analysis of genes coding for 16S rRNA in Veillonella spp. Int. J. Syst. Bacteriol. 47: 1268– 1270.

112. Seng, P.,, M. Drancourt,, F. Gouriet,, B. La Scala,, P.-E. Fournier,, J. M. Rolain,, and D. Raoult. 2009. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Infect. Dis. 49: 543– 551.

113. Singh, N.,, and V. L. Yu. 1992. Osteomyelitis due to Veillonella parvula: case report and review. Clin. Infect. Dis. 14: 361– 363.

114. Siqueira, J. F., Jr.,, I. N. Rôças,, A. F. Andrade,, and M. de Uzeda. 2003. Peptostreptococcus micros in primary endodontic infections as detected by 16S rDNA-based polymerase chain reaction. J. Endod. 29: 111– 113.

115. Siqueira, J. F., Jr.,, and I. N. Rôças. 2008. The microbiota of acute apical abscesses. J. Dent. Res. 88: 61– 65.

116. Smayevsky, J.,, L. F. Canigia,, A. Lanza,, and H. Bianchini. 2001. Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection. Infect. Dis. Obstet. Gynecol. 9: 17– 22.

117. Song, Y.,, C. Liu,, M. McTeague,, and S. M. Finegold. 2003. 16S ribosomal DNA sequence-based analysis of clinically significant gram-positive anaerobic cocci. J. Clin. Microbiol. 41: 1363– 1369.

118. Song, Y.,, C. Liu,, and S. M. Finegold. 2007. Development of a flow chart for identification of gram-positive anaerobic cocci in the clinical laboratory. J. Clin. Microbiol. 45: 512– 516.

119. Song, Y.,, C. Liu,, and S. M. Finegold. 2007. Peptoniphilus gorbachii sp. nov., Peptoniphilus olsenii sp. nov., and Anaerococcus murdochii sp. nov. isolated from clinical specimens of human origin. J. Clin. Microbiol. 45: 1746– 1752.

120. Song, Y.,, C. Liu,, M. McTeague,, A. Vu,, J. Y. Liu,, and S. M. Finegold. 2003. Rapid identification of Gram-positive anaerobic coccal species originally classified in the genus Peptostreptococcus by multiplex PCR assays using genus- and species-specific primers. Microbiology 149: 1719– 1727.

121. Sotto, A.,, N. Bouziges,, N. Jordan,, J.-L. Richard,, and J.-P. Lavigne. 2007. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers. Pathol. Biologie 55: 398– 406.

122. Subramanian, K.,, and A. K. Mickel. 2009. Molecular analysis of persistent periradicular lesions and root ends reveals a diverse microbial profile. J. Endod. 35: 950– 957.

123. Summanen, P. H.,, D. A. Talan,, C. Strong,, M. McTeague,, R. Bennion,, J. E. Thompson, Jr.,, M.-L. Väisänen,, G. Moran,, M. Winer,, and S. M. Finegold. 1995. Bacteriologyof skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin. Infect. Dis. 20( Suppl. 2): S279– S282.

124. Sutter, V. L. 1984. Anaerobes as normal oral flora. Rev. Infect. Dis. 6: S62– S66.

125. Tindall, B. J.,, and J. P. Euzéby. 2002. Proposal of Parvimonas gen. nov. and Quatrionicoccus gen. nov. as replacements for the illegitimate, prokaryotic, generic names Micromonas Murdoch and Shah 2000 and Quadricoccus Maszenan et al. 2002, respectively. Int. J. Syst. Evol. Microbiol. 56: 2711– 2713.

126. Turng, B.-F.,, J. M. Guthmiller,, G. E. Minah,, and W. A. Falkler, Jr. 1996. Development and evaluation of a selective and differential medium for the primary isolation of Peptostreptococcus micros. Oral Microbiol. Immunol. 5: 356– 361.

127. Tyrrell, K. L.,, D. M. Citron,, Y. A. Warren,, H. T. Fernandez,, C. V. Merriam,, and E. J. C. Goldstein. 2006. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes. Antimicrob. Agents Chemother. 50: 2728– 2731.

128. Ulger-Toprak, N.,, C. Liu,, P. H. Summanen,, and S. M. Finegold. 2010. Murdochiella asaccharolytica gen. nov., sp. nov., a gram-positive, anaerobic coccus isolated from human wound specimens. Int. J. Syst. Evol. Microbiol. 60: 1013– 1016.

129. Verma, P. 2000. Laboratory diagnosis of anaerobic pleuropulmonary infections. Semin. Respir. Infect. 15: 114– 118.

130. Wade, W. G.,, J. Moran,, J. R. Morgan,, R. Newcombe,, and M. Addy. 1992. The effects of antimicrobial acrylic strips on the subgingival microflora in chronic periodontitis. J. Clin. Periodontol. 19: 127– 134.

131. Watt, B.,, and F. V. Brown. 1986. Is ciprofloxacin active against clinically important anaerobes? J. Antimicrob. Chemother. 17: 605– 613.

132. Wildeboer-Veloo, A. C.,, H. J. Harmsen,, G. W. Welling,, and J. E. Degener. 2007. Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens. Clin. Microbiol. Infect. 13: 985– 992.

133. Woo, P. C. Y.,, L. M. W. Chung,, J. L. L. Teng,, H. Tse,, S. S. Y. Pang,, V. Y. T. Lau,, V. W. K. Wong,, K.-L. Kam,, S. K. P. Lau,, and K.-Y. Yuen. 2007. In silico analysis of 16S ribosomal RNA gene sequencing-based methods for identification of medically important anaerobic bacteria. J. Clin. Pathol. 60: 576– 579.

134. Wren, M. W. D. 1996. Anaerobic cocci of clinical importance. Br. J. Biomed. Sci. 53: 294– 301.

Tables

Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci

/content/10.1128/9781555816728.chap48.tab48-1

TABLE 1

Changes in classification of gram-positive anaerobic coccal species from human clinical specimens

10.1128/9781555816728/tab48-1_thmb.gif

10.1128/9781555816728/tab48-1.gif

TABLE 1

Changes in classification of gram-positive anaerobic coccal species from human clinical specimens

/content/10.1128/9781555816728.chap48.tab48-2

TABLE 2

Differential characteristics of Peptostreptococcus, Peptococcus, Peptoniphilus, Finegoldia, and Anaerococcus a

a Data are mainly from Murdoch ( 82 ) and Song et al. ( 118 ); Undescribed strains that cluster in whole-cell composition were assessed by pyrolysis mass spectrometry. VFA, volatile fatty acids; A, acetate; B, butyrate; IV, isovalerate; IC, isocaproate; C, n-caproate; SPS, sodium polyanethol sulfonate; ALP, alkaline phosphatase; ADH, arginine dihydrolase; α-Gal, α-galactosidase; β-Gal, β-galactosidase; α-Glu, α-glucosidase; β-Gur, β-glucuronidase; ArgA, arginine arylamidase (AMD); ProA, proline AMD; PheA, phenylalanine AMD; Leu, leucine AMD; PyrA, pyroglutamyl AMD; –, >90% negative; w, weakly positive; +, >90% positive; d, different reactions.

10.1128/9781555816728/tab48-2_thmb.gif

10.1128/9781555816728/tab48-2.gif

TABLE 2

Differential characteristics of Peptostreptococcus, Peptococcus, Peptoniphilus, Finegoldia, and Anaerococcus a

/content/10.1128/9781555816728.chap48.tab48-3

TABLE 3

Characteristics of genera of gram-negative cocci a

a Modified from reference 72 . A, acetate; B, butyrate; IB, isobutyrate; V, valerate; IV, isovalerate; C, n-caproate; P, propionate; L, lactate. Parentheses indicate possible production.

b Glucose fermentation tests were performed using pre-reduced, anaerobically sterilized PRAS peptone-yeast-glucose broth tubes (Anaerobe Systems, Morgan Hill, CA). The PRAS tubes were inoculated from an actively growing broth culture (without carbohydrate). A pH of ≤5.5 in the PRAS tubes was interpreted as positive, a pH of 5.6 to 5.8 as weakly positive, and a pH of ≥5.9 as negative fermentation.

10.1128/9781555816728/tab48-3_thmb.gif

10.1128/9781555816728/tab48-3.gif

TABLE 3

Characteristics of genera of gram-negative cocci a

a Modified from reference 72 . A, acetate; B, butyrate; IB, isobutyrate; V, valerate; IV, isovalerate; C, n-caproate; P, propionate; L, lactate. Parentheses indicate possible production.

/content/10.1128/9781555816728.chap48.tab48-4

TABLE 4

Antimicrobial susceptibilities of gram-positive anaerobic cocci a

a Data were obtained from the Wadsworth Anaerobic Bacteriology Laboratory. Strains were tested by CLSI (formerly NCCLS) agar dilution procedures. Pen, penicillin; Amp-Sul, amoxicillin-sulbactam; Amp-Clav, amoxicillin-clavulanic acid; Pip-Tazo, piperacillin-tazobactam; Cefox, cefoxitin; Imi, imipenem; Clinda, clindamycin; Metro, metronidazole; Cipro, ciprofloxacin; ND, no data.

b One of 5 strains showed resistance.

c Three of 16 strains showed resistance.

d Two of 15 strains showed resistance.

e Three of 16 strains showed resistance.

f One of 5 strains showed resistance.

g Data were obtained from Könönen et al. ( 63 ). Strains were tested by the Etest (AB Biodisk).

h Numbers in parentheses are applied breakpoints for testing the antimicrobial agents.

i Results for this drug combination are given for amoxicillin and piperacillin.

10.1128/9781555816728/tab48-4_thmb.gif

10.1128/9781555816728/tab48-4.gif

TABLE 4

Antimicrobial susceptibilities of gram-positive anaerobic cocci a

b One of 5 strains showed resistance.

c Three of 16 strains showed resistance.

d Two of 15 strains showed resistance.

e Three of 16 strains showed resistance.

f One of 5 strains showed resistance.

g Data were obtained from Könönen et al. ( 63 ). Strains were tested by the Etest (AB Biodisk).

h Numbers in parentheses are applied breakpoints for testing the antimicrobial agents.

i Results for this drug combination are given for amoxicillin and piperacillin.